Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization
• An isothermal internal seeding anti-solvent crystallization process is proposed. • The process selectively produces metastable δ-polymorph of pyrazinamide. • Plate-shaped δ-polymorph crystals are best characterized by their length and width. • Effect of important process variables on particle leng...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Digarse, Harshika [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
A2. Industrial crystallization A1. Solubility of pyrazinamide |
|---|
| Übergeordnetes Werk: |
Enthalten in: The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting - 2011, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:526 ; year:2019 ; day:15 ; month:11 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jcrysgro.2019.125245 |
|---|
| Katalog-ID: |
ELV048042986 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV048042986 | ||
| 003 | DE-627 | ||
| 005 | 20230624142524.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191023s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jcrysgro.2019.125245 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000761.pica |
| 035 | |a (DE-627)ELV048042986 | ||
| 035 | |a (ELSEVIER)S0022-0248(19)30460-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 570 |a 540 |q VZ |
| 100 | 1 | |a Digarse, Harshika |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization |
| 264 | 1 | |c 2019 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • An isothermal internal seeding anti-solvent crystallization process is proposed. • The process selectively produces metastable δ-polymorph of pyrazinamide. • Plate-shaped δ-polymorph crystals are best characterized by their length and width. • Effect of important process variables on particle length and width is analyzed. | ||
| 650 | 7 | |a A2. Industrial crystallization |2 Elsevier | |
| 650 | 7 | |a A1. Solubility of pyrazinamide |2 Elsevier | |
| 650 | 7 | |a A1. Anti-solvent crystallization |2 Elsevier | |
| 650 | 7 | |a A1. Crystal morphology |2 Elsevier | |
| 700 | 1 | |a Sarkar, Debasis |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |t The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting |d 2011 |g Amsterdam [u.a.] |w (DE-627)ELV010662650 |
| 773 | 1 | 8 | |g volume:526 |g year:2019 |g day:15 |g month:11 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jcrysgro.2019.125245 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_105 | ||
| 951 | |a AR | ||
| 952 | |d 526 |j 2019 |b 15 |c 1115 |h 0 | ||
| author_variant |
h d hd |
|---|---|
| matchkey_str |
digarseharshikasarkardebasis:2019----:rdcinfhmtsalplmrhcomfyaiaieystemlnenled |
| hierarchy_sort_str |
2019 |
| publishDate |
2019 |
| allfields |
10.1016/j.jcrysgro.2019.125245 doi GBV00000000000761.pica (DE-627)ELV048042986 (ELSEVIER)S0022-0248(19)30460-9 DE-627 ger DE-627 rakwb eng 610 VZ 570 540 VZ Digarse, Harshika verfasserin aut Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization 2019 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • An isothermal internal seeding anti-solvent crystallization process is proposed. • The process selectively produces metastable δ-polymorph of pyrazinamide. • Plate-shaped δ-polymorph crystals are best characterized by their length and width. • Effect of important process variables on particle length and width is analyzed. A2. Industrial crystallization Elsevier A1. Solubility of pyrazinamide Elsevier A1. Anti-solvent crystallization Elsevier A1. Crystal morphology Elsevier Sarkar, Debasis oth Enthalten in Elsevier The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting 2011 Amsterdam [u.a.] (DE-627)ELV010662650 volume:526 year:2019 day:15 month:11 pages:0 https://doi.org/10.1016/j.jcrysgro.2019.125245 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_105 AR 526 2019 15 1115 0 |
| spelling |
10.1016/j.jcrysgro.2019.125245 doi GBV00000000000761.pica (DE-627)ELV048042986 (ELSEVIER)S0022-0248(19)30460-9 DE-627 ger DE-627 rakwb eng 610 VZ 570 540 VZ Digarse, Harshika verfasserin aut Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization 2019 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • An isothermal internal seeding anti-solvent crystallization process is proposed. • The process selectively produces metastable δ-polymorph of pyrazinamide. • Plate-shaped δ-polymorph crystals are best characterized by their length and width. • Effect of important process variables on particle length and width is analyzed. A2. Industrial crystallization Elsevier A1. Solubility of pyrazinamide Elsevier A1. Anti-solvent crystallization Elsevier A1. Crystal morphology Elsevier Sarkar, Debasis oth Enthalten in Elsevier The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting 2011 Amsterdam [u.a.] (DE-627)ELV010662650 volume:526 year:2019 day:15 month:11 pages:0 https://doi.org/10.1016/j.jcrysgro.2019.125245 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_105 AR 526 2019 15 1115 0 |
| allfields_unstemmed |
10.1016/j.jcrysgro.2019.125245 doi GBV00000000000761.pica (DE-627)ELV048042986 (ELSEVIER)S0022-0248(19)30460-9 DE-627 ger DE-627 rakwb eng 610 VZ 570 540 VZ Digarse, Harshika verfasserin aut Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization 2019 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • An isothermal internal seeding anti-solvent crystallization process is proposed. • The process selectively produces metastable δ-polymorph of pyrazinamide. • Plate-shaped δ-polymorph crystals are best characterized by their length and width. • Effect of important process variables on particle length and width is analyzed. A2. Industrial crystallization Elsevier A1. Solubility of pyrazinamide Elsevier A1. Anti-solvent crystallization Elsevier A1. Crystal morphology Elsevier Sarkar, Debasis oth Enthalten in Elsevier The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting 2011 Amsterdam [u.a.] (DE-627)ELV010662650 volume:526 year:2019 day:15 month:11 pages:0 https://doi.org/10.1016/j.jcrysgro.2019.125245 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_105 AR 526 2019 15 1115 0 |
| allfieldsGer |
10.1016/j.jcrysgro.2019.125245 doi GBV00000000000761.pica (DE-627)ELV048042986 (ELSEVIER)S0022-0248(19)30460-9 DE-627 ger DE-627 rakwb eng 610 VZ 570 540 VZ Digarse, Harshika verfasserin aut Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization 2019 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • An isothermal internal seeding anti-solvent crystallization process is proposed. • The process selectively produces metastable δ-polymorph of pyrazinamide. • Plate-shaped δ-polymorph crystals are best characterized by their length and width. • Effect of important process variables on particle length and width is analyzed. A2. Industrial crystallization Elsevier A1. Solubility of pyrazinamide Elsevier A1. Anti-solvent crystallization Elsevier A1. Crystal morphology Elsevier Sarkar, Debasis oth Enthalten in Elsevier The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting 2011 Amsterdam [u.a.] (DE-627)ELV010662650 volume:526 year:2019 day:15 month:11 pages:0 https://doi.org/10.1016/j.jcrysgro.2019.125245 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_105 AR 526 2019 15 1115 0 |
| allfieldsSound |
10.1016/j.jcrysgro.2019.125245 doi GBV00000000000761.pica (DE-627)ELV048042986 (ELSEVIER)S0022-0248(19)30460-9 DE-627 ger DE-627 rakwb eng 610 VZ 570 540 VZ Digarse, Harshika verfasserin aut Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization 2019 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • An isothermal internal seeding anti-solvent crystallization process is proposed. • The process selectively produces metastable δ-polymorph of pyrazinamide. • Plate-shaped δ-polymorph crystals are best characterized by their length and width. • Effect of important process variables on particle length and width is analyzed. A2. Industrial crystallization Elsevier A1. Solubility of pyrazinamide Elsevier A1. Anti-solvent crystallization Elsevier A1. Crystal morphology Elsevier Sarkar, Debasis oth Enthalten in Elsevier The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting 2011 Amsterdam [u.a.] (DE-627)ELV010662650 volume:526 year:2019 day:15 month:11 pages:0 https://doi.org/10.1016/j.jcrysgro.2019.125245 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_105 AR 526 2019 15 1115 0 |
| language |
English |
| source |
Enthalten in The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting Amsterdam [u.a.] volume:526 year:2019 day:15 month:11 pages:0 |
| sourceStr |
Enthalten in The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting Amsterdam [u.a.] volume:526 year:2019 day:15 month:11 pages:0 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
A2. Industrial crystallization A1. Solubility of pyrazinamide A1. Anti-solvent crystallization A1. Crystal morphology |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting |
| authorswithroles_txt_mv |
Digarse, Harshika @@aut@@ Sarkar, Debasis @@oth@@ |
| publishDateDaySort_date |
2019-01-15T00:00:00Z |
| hierarchy_top_id |
ELV010662650 |
| dewey-sort |
3610 |
| id |
ELV048042986 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV048042986</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624142524.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jcrysgro.2019.125245</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000761.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV048042986</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0022-0248(19)30460-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Digarse, Harshika</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• An isothermal internal seeding anti-solvent crystallization process is proposed. • The process selectively produces metastable δ-polymorph of pyrazinamide. • Plate-shaped δ-polymorph crystals are best characterized by their length and width. • Effect of important process variables on particle length and width is analyzed.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">A2. Industrial crystallization</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">A1. Solubility of pyrazinamide</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">A1. Anti-solvent crystallization</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">A1. Crystal morphology</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sarkar, Debasis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="t">The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting</subfield><subfield code="d">2011</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV010662650</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:526</subfield><subfield code="g">year:2019</subfield><subfield code="g">day:15</subfield><subfield code="g">month:11</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jcrysgro.2019.125245</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">526</subfield><subfield code="j">2019</subfield><subfield code="b">15</subfield><subfield code="c">1115</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Digarse, Harshika |
| spellingShingle |
Digarse, Harshika ddc 610 ddc 570 Elsevier A2. Industrial crystallization Elsevier A1. Solubility of pyrazinamide Elsevier A1. Anti-solvent crystallization Elsevier A1. Crystal morphology Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization |
| authorStr |
Digarse, Harshika |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV010662650 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 570 540 VZ Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization A2. Industrial crystallization Elsevier A1. Solubility of pyrazinamide Elsevier A1. Anti-solvent crystallization Elsevier A1. Crystal morphology Elsevier |
| topic |
ddc 610 ddc 570 Elsevier A2. Industrial crystallization Elsevier A1. Solubility of pyrazinamide Elsevier A1. Anti-solvent crystallization Elsevier A1. Crystal morphology |
| topic_unstemmed |
ddc 610 ddc 570 Elsevier A2. Industrial crystallization Elsevier A1. Solubility of pyrazinamide Elsevier A1. Anti-solvent crystallization Elsevier A1. Crystal morphology |
| topic_browse |
ddc 610 ddc 570 Elsevier A2. Industrial crystallization Elsevier A1. Solubility of pyrazinamide Elsevier A1. Anti-solvent crystallization Elsevier A1. Crystal morphology |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
d s ds |
| hierarchy_parent_title |
The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting |
| hierarchy_parent_id |
ELV010662650 |
| dewey-tens |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry |
| hierarchy_top_title |
The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV010662650 |
| title |
Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization |
| ctrlnum |
(DE-627)ELV048042986 (ELSEVIER)S0022-0248(19)30460-9 |
| title_full |
Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization |
| author_sort |
Digarse, Harshika |
| journal |
The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting |
| journalStr |
The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Digarse, Harshika |
| container_volume |
526 |
| class |
610 VZ 570 540 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Digarse, Harshika |
| doi_str_mv |
10.1016/j.jcrysgro.2019.125245 |
| dewey-full |
610 570 540 |
| title_sort |
production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization |
| title_auth |
Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization |
| abstract |
• An isothermal internal seeding anti-solvent crystallization process is proposed. • The process selectively produces metastable δ-polymorph of pyrazinamide. • Plate-shaped δ-polymorph crystals are best characterized by their length and width. • Effect of important process variables on particle length and width is analyzed. |
| abstractGer |
• An isothermal internal seeding anti-solvent crystallization process is proposed. • The process selectively produces metastable δ-polymorph of pyrazinamide. • Plate-shaped δ-polymorph crystals are best characterized by their length and width. • Effect of important process variables on particle length and width is analyzed. |
| abstract_unstemmed |
• An isothermal internal seeding anti-solvent crystallization process is proposed. • The process selectively produces metastable δ-polymorph of pyrazinamide. • Plate-shaped δ-polymorph crystals are best characterized by their length and width. • Effect of important process variables on particle length and width is analyzed. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_105 |
| title_short |
Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization |
| url |
https://doi.org/10.1016/j.jcrysgro.2019.125245 |
| remote_bool |
true |
| author2 |
Sarkar, Debasis |
| author2Str |
Sarkar, Debasis |
| ppnlink |
ELV010662650 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1016/j.jcrysgro.2019.125245 |
| up_date |
2024-07-06T17:48:25.921Z |
| _version_ |
1803852820955267072 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV048042986</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624142524.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jcrysgro.2019.125245</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000761.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV048042986</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0022-0248(19)30460-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Digarse, Harshika</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Production of the metastable δ-polymorphic form of pyrazinamide by isothermal internal seeding anti-solvent crystallization</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• An isothermal internal seeding anti-solvent crystallization process is proposed. • The process selectively produces metastable δ-polymorph of pyrazinamide. • Plate-shaped δ-polymorph crystals are best characterized by their length and width. • Effect of important process variables on particle length and width is analyzed.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">A2. Industrial crystallization</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">A1. Solubility of pyrazinamide</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">A1. Anti-solvent crystallization</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">A1. Crystal morphology</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sarkar, Debasis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="t">The mental health of doctor-shoppers: Experience from a patient-led fee-for-service primary care setting</subfield><subfield code="d">2011</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV010662650</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:526</subfield><subfield code="g">year:2019</subfield><subfield code="g">day:15</subfield><subfield code="g">month:11</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jcrysgro.2019.125245</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">526</subfield><subfield code="j">2019</subfield><subfield code="b">15</subfield><subfield code="c">1115</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.4021616 |